
Empacoza Trio Extended Release Film coated Tablct
Product Details:
- Active: Empagliflozin + Metformin + Linagliptin
- Concentration: 25 mg + 1 g + 5 mg / 10 mg + 1g + 5 mg
- Speciality: All Specialities
Leaflet :


Description :
INDICATIONS AND USAGE :
• EMPACOZA TRIO is a combination of empagliflozin, linagliptin, and metformin
hydrochloride (HCl) indicated as an adjunct to diet and exercise to improve
glycemic control in adults with type 2 diabetes mellitus.
• Empagliflozin is indicated to reduce the risk of cardiovascular death in adults with
type 2 diabetes mellitus and established cardiovascular disease
Contact Us
Our Location
36 Al Sheikh Mohammed Al Nadi St., Off Mostafa El Nahaas St. 6th District. Nasr City, Cairo, Egypt.